Our results also show that these antitumor effects were not associated with detectable differences in the numbers of infiltrating T-cells and microglia, suggesting that tumor cell-derived STAT3 represents the primary target of LPP-PEI-siRNA in vivo. This evidence concerns the gene STAT3 and neoplasm.